Direct cytosolic co-delivery of siRNA and tamoxifen for enhanced breast cancer therapy

被引：0
|
作者：
Hardie, Joseph [1 ]
Jiang, Ying [1 ]
Tetrault, Emily [2 ]
Ghazi, Phaedra [1 ]
Tonga, Gulen Yesilbag [1 ]
Farkas, Michelle [3 ]
Rotello, Vincent [1 ]
机构：
[1] Univ Massachusetts, Amherst, MA 01003 USA
[2] Mt Holyoke Coll, S Hadley, MA 01075 USA
[3] Univ Massachusetts, Chem, Amherst, MA 01003 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 256卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
208
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Simultaneous cytosolic delivery of siRNA and chemotherapeutics for enhanced breast cancer therapy
    Hardie, Joseph
    Jiang, Ying
    Tetrault, Emily
    Ghazi, Phaedra
    Tonga, Gulen Yesilbag
    Farkas, Michelle
    Rotello, Vincent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [2] Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy
    Senel, Behiye
    Basaran, Ebru
    Akyil, Evrim
    Guven, Umay Merve
    Buyukkoroglu, Gulay
    ACS OMEGA, 2024, 9 (10): : 11671 - 11685
  • [3] Current Status of Natural Products/siRNA Co-Delivery for Cancer Therapy
    Jacob, Megha Mariya
    Santhosh, Amritha
    Rajeev, Anjaly
    Joy, Reshma
    John, Pooja Mary
    John, Franklin
    George, Jinu
    CHEMISTRYSELECT, 2022, 7 (44):
  • [4] Co-delivery of STAT3 siRNA and methotrexate in breast cancer cells
    Shakeran, Zahra
    Varshosaz, Jaleh
    Keyhanfar, Mehrnaz
    Mohammad-Beigi, Hossein
    Rahimi, Karim
    Sutherland, Duncan S.
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) : 29 - 39
  • [5] Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
    Ashrafizadeh, Milad
    Zarrabi, Ali
    Hushmandi, Kiavash
    Hashemi, Farid
    Moghadam, Ebrahim Rahmani
    Raei, Mehdi
    Kalantari, Mahshad
    Tavakol, Shima
    Mohammadinejad, Reza
    Najafi, Masoud
    Tay, Franklin R.
    Makvandi, Pooyan
    ACS COMBINATORIAL SCIENCE, 2020, 22 (12) : 669 - 700
  • [6] The importance of co-delivery of nanoparticle-siRNA and anticancer agents in cancer therapy
    Khelghati, Nafiseh
    Soleimanpour Mokhtarvand, Jafar
    Mir, Mostafa
    Alemi, Forough
    Asemi, Zatollah
    Sadeghpour, Alireza
    Maleki, Masomeh
    Samadi Kafil, Hossein
    Jadidi-niaragh, Farhad
    Majidinia, Maryam
    Yousefi, Bahman
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (04) : 997 - 1015
  • [7] Co-delivery of paclitaxel and survivin siRNA with cationic liposome for lung cancer therapy
    Zhang, Chuanmin
    Zhang, Shubiao
    Zhi, Defu
    Zhao, Yinan
    Cui, Shaohui
    Cui, Jingnan
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2020, 585 (585)
  • [8] Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA
    Ball, Rebecca L.
    Hajj, Khalid A.
    Vizelman, Jamie
    Bajaj, Palak
    Whitehead, Kathryn A.
    NANO LETTERS, 2018, 18 (06) : 3814 - 3822
  • [9] Microfluidic fabrication of lipid nanoparticles for co-delivery of siRNA and hydroxychloroquine: An engineered theranostic platform for enhanced breast cancer treatment
    Huang, Lu
    Guo, Wenli
    Zhao, Ting
    Feng, Yanru
    Li, Yue
    An, Qingqing
    Li, Chenxi
    Tian, Yiwei
    Zhang, Huaxing
    Zhou, Chenming
    Sun, Yanan
    He, Chaoxing
    Niu, Zhiyun
    Shen, Haitao
    Xiang, Bai
    CHEMICAL ENGINEERING JOURNAL, 2025, 506
  • [10] Cationic liposomes for co-delivery of paclitaxel and anti-Plk1 siRNA to achieve enhanced efficacy in breast cancer
    Bulbake, Upendra
    Kommineni, Nagavendra
    Bryszewska, Maria
    Ionov, Maksim
    Khan, Wahid
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 48 : 253 - 265
12345